Ágnes Molnár

RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition

Sándor Kőszegi, Ágnes Molnár, Lilla Lénárt et al. · The Journal of Physiology · 2018 · 96 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Lyophilization and homogenization of biological samples improves reproducibility and reduces standard deviation in molecular biology techniques

Ágnes Molnár, Tamás Lakat, Ádám Hosszú et al. · Amino Acids · 2021 · 68 citations · Full text

Pharmacy, Biochemistry, Molecular Biology +17

Role of<i>O</i>-linked<i>N</i>-acetylglucosamine modification in diabetic nephropathy

Renáta Gellai, Judit Hodrea, Lilla Lénárt et al. · American Journal of Physiology-Renal Physiology · 2016 · 55 citations · Full text

Life Sciences, Biochemistry, Nephrology +17

SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes

Judit Hodrea, Adar Saeed, Ágnes Molnár et al. · PLoS ONE · 2022 · 36 citations · Full text

Medicine, Cardiology, Pharmacology +17

Polymorphisms of the <i>GR</i> and <i>HSD11B1</i> genes influence body mass index and weight gain during hormone replacement treatment in patients with Addison's disease

Ágnes Molnár, Annamária Kövesdi, Nikolette Szücs et al. · Clinical Endocrinology · 2016 · 34 citations

Life Sciences, Endocrinology, Genetics +8